French authorise embryonic stem cell lines:
This article was originally published in Clinica
Executive Summary
The development of new diagnostics and medicines are two of the reasons cited by the French Research Minister, Roger-Gerard Schwartzenberg, for authorising the import of two embryonic stem cell lines on May 3, three days before the government stepped down following the re-election of President Jacques Chirac. His successor will have to confirm or revoke the authorisation, which was made after the lower house of parliament agreed on the principle of research on such cells when it passed the bioethics bill. The bill is unlikely to become law until 2003, but the ready availability to French researchers of the stem cell lines is intended to help speed matters.
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.